Provider review, September 2026
Royal Medical Centers publishes its entire peptide catalogue as eleven separate product pages, each with a one-month and a two-month price, and prints a compounding disclaimer on every one. Three of the eleven are blends, so three tracked compounds carry a scoped figure and the rest do not.
Royal Medical Centers also sells 5 compounds this site boards without publishing a price for them: GHK-Cu, BPC-157 (board ranks no provider), TB-500 (board ranks no provider), Ipamorelin (board ranks no provider) and CJC-1295 (board ranks no provider).
Royal Medical Centers is not a paid partner; this link may earn a commission if that changes. Full disclosure.
The peptide category publishes a machine-readable feed that lists every product in it. There are eleven, and they were read as a list rather than sampled from a homepage.
That matters for anything said here about what this seller does not sell. An absence measured against a homepage is not an absence; an absence measured against a complete catalogue is.
Two of the eleven are compounds this site does not track at all, and four are blends of two or three peptides.
MOTS-C is priced for one month, with a two-month figure beside it. The page prints the same monthly figure twice, once in prose and once in a pricing line.
Sermorelin acetate is priced per month, again with a two-month figure.
Tesamorelin is priced for one month against a stated vial strength and volume that the page itself describes as a one-month supply, which is the only listing here where the month can be checked against a quantity.
A copper-peptide, BPC-157 and TB-500 injection is priced for one month. A tesamorelin and ipamorelin injection is priced for one month. A three-ingredient metabolic blend is priced for one month. A CJC and ipamorelin injection is listed as well.
Filing any of those figures under a single ingredient would put a multi-drug price on a single-compound board.
The compounds are declared because this seller genuinely dispenses them. What is missing is a price scoped to any one of them.
Its own disclaimer says the FDA does not verify the safety, effectiveness or quality of compounded drugs offered at the clinic, and that compounded drugs are not FDA-approved and do not undergo safety, effectiveness or manufacturing review.
It says medications are dispensed by licensed pharmacies and that a provider may prescribe a drug prepared by a state-licensed sterile compounding pharmacy partner. No partner is named.
No state list is published and no certificate of analysis is reachable. A meaningless address on this host returns a not-found response, so both are absences rather than an artefact of the host.
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Read the full Trellis Vitality review
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis VitalityEleven products, read from the category's own feed rather than counted off a page. Four are blends and two are compounds this site does not track.
Because the page prints a vial strength and volume and calls that a one-month supply. The month the price covers can be checked against a quantity rather than taken on trust.
The opposite. It says compounded drugs are not FDA-approved and do not undergo safety, effectiveness or manufacturing review, in its own disclaimer.
Each product prints a two-month figure lower than twice the one-month figure. Those figures are recorded in the qualifier on each price row rather than as separate prices.
Royal Medical Centers is not a paid partner; this link may earn a commission if that changes. Full disclosure.